Add to the above ..
Non-dilutive funding
o Partnerships - clear feedback received on importance/value of placebo-controlled study results
So they have been in discussions on partnerships and the other party wants more confirmation...
Applications to be submitted now for the trial....looks a bit ambitious to expect approvals in this year especially things start to slow down next month...
But as mentioned in the resport plenty of positives to look forward to in the next few months ....
We have more than a decent pipeline of indications to chase....starting with DMD..
Interest in LC has been mentioned and that looks set sooner or later...
Nice preso overall and agree with a few it's has been the best one so far...and plenty to look forward to....
Ann: AGM Presentation, page-25
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $94.66M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 9.8¢ | $58.09K | 574.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 38503 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 194063 | 5 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |